Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2012
The primary objective is to demonstrate the non-inferiority of bevacizumab in the treatment of patients with macular edema secondary to a retinal vein occlusion (branch or central) as determined by the change in best-corrected visual acuity in the study eye from baseline to month 6.
Epistemonikos ID: 2f07c2a6bbd3c66400e53fcd52837353b3f66015
First added on: May 11, 2024